Go to deals
Business Support Services | Healthcare | Private Equity

BlijWerkt has been acquired by Mentha Capital

Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.

BlijWerkt is a Dutch provider of occupational health services that help companies manage employee absenteeism. The firm reduces the costs of absenteeism by increasing the vitality of client organizations and their employees. It also manages the process of sick leave and reintegration. BlijWerkt combines the power of the bigger players with the flexibility and personal attention of the smaller ones. The company is headquartered in Woerden, the Netherlands and is owned by Gilde Healthcare Partners, a Dutch private equity investor, since 2011. BlijWerkt has a diversified client base and is mainly active in the healthcare, government and educational sectors. The Group’s solutions are a high impact, mandatory service of negligible cost to its clients, which results in recurring revenues of +95%.

Mentha Capital is an independent investment company that focuses on the lower-end of the mid-market in the Benelux. Mentha invests in established, medium-sized and profitable companies that have the opportunity to grow further through a buy-and-build strategy, expansion into new markets or an organizational transition. With more than €400 million under management, Mentha works actively with entrepreneurs to support their companies in realizing their ambitious growth plans.

Gilde Healthcare is a specialized European healthcare investor managing €1 billion across two fund strategies: venture and growth capital and private equity. Gilde Healthcare's venture and growth capital fund invests in health tech and therapeutics. The venture and growth companies are based in Europe and North America. Gilde Healthcare's private equity fund invests in profitable European lower mid-market healthcare companies with a focus on the Benelux and DACH region. The private equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market.

Oaklins’ team in the Netherlands acted as the exclusive M&A advisor to the shareholders of BlijWerkt Groep B.V., including the majority shareholder Gilde Healthcare Partners.

Parties
“We are very grateful to Oakins for their support on this, behind the scenes, complex transaction. They have clearly proven their added value as they were able to quickly understand the essence of the business and structure the process in such a way that it benefited us, but also prospective acquirors. Throughout the process, the Oaklins team has proven to be a dedicated and knowledgeable partner to us.”

Hugo de Bruin

Partner, Gilde Healthcare Partners

Talk to the deal team

Frederik van der Schoot

Managing Partner
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Bluegem Capital Partners and AREV Partners have acquired 100% of Groupe Pinard
Private Equity | Consumer & Retail | Other Industries

Bluegem Capital Partners and AREV Partners have acquired 100% of Groupe Pinard

Bluegem Capital Partners and AREV Partners have successfully completed the acquisition of the prestigious Groupe Pinard from IK Partners.

Learn more
Lumiforte partners with Kartesia to propel global growth and innovation
Private Equity | Agriculture | Other Industries

Lumiforte partners with Kartesia to propel global growth and innovation

Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.

Learn more
PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
Healthcare

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

Learn more